Prediction of Mutant mRNA Splice Isoforms by Information Theory-Based Exon Definition

Human Mutation

Volumn 34, Issue 4, 2013, Pages 557-565

  Mucaki, Eliseos J ^a   Shirley, Ben C ^a   Rogan, Peter K ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Cryptic splicing; Exon definition; Gap surprisal; Information theory; MRNA

Indexed keywords

MESSENGER RNA; RNA ISOFORM;

ARTICLE; AUTOMATED SPLICE SITE AND EXON DEFINITION ANALYSIS; BINDING SITE; EXON; EXON SKIPPING; GENE MUTATION; PHENOTYPE; PRIORITY JOURNAL; RNA ANALYSIS; RNA PROCESSING; RNA SPLICING;

ALGORITHMS; COMPUTATIONAL BIOLOGY; DATABASES, NUCLEIC ACID; EXONS; INFORMATION THEORY; MOLECULAR SEQUENCE ANNOTATION; MUTATION; REGULATORY SEQUENCES, NUCLEIC ACID; REPRODUCIBILITY OF RESULTS; RNA ISOFORMS; RNA SPLICING;

EID: 84875550381     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22277     Document Type: Article

References (36)

1. Berget SM. 1995. Exon recognition in vertebrate splicing. J Biol Chem 270:2411-2414.
2. Bolisetty MT, Beemon KL. 2012. Splicing of internal large exons is defined by novel cis-acting sequence elements. Nucleic Acids Res 40(18):9244-9254.
3. Cartegni L, Krainer AR. 2002. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 30:377-384.
4. Claes K, Poppe B, Machackova E, Coene I, Foretova L, De Paepe A, Messiaen L. 2003. Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2. Genes Chromosomes Cancer 37:314-320.
5. Claes K, Vandesompele J, Poppe B, Dahan K, Coene I, De Paepe A, Messiaen L. 2002. Pathological splice mutations outside the invariant AG/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5′ end of the BRCA1 gene. Oncogene 21:4171-4175.
6. Clark F, Thanaraj TA. 2002. Categorization and characterization of transcript-confirmed constitutively and alternatively spliced introns and exons from human. Hum Mol Genet 11: 451-464.
7. Cover TM, Thomas JA. 2006. Elements of information theory. Hoboken, NJ: Wiley-Interscience, p. 748.
8. Dalgleish R, Flicek P, Cunningham F, Astashyn A, Tully RE, Proctor G, Chen Y, McLaren WM, Larsson P, Vaughan BW, Beroud C, Dobson G, et al. 2010. Locus Reference genomic sequences: an improved basis for describing human DNA variants. Genome Med 2:24.
9. De Conti L, Baralle M, Buratti E. 2013. Exon and intron definition in pre-mRNA splicing. Wiley Interdiscip Rev RNA 4(1):49-60.
10. Divina P, Kvitkovicova A, Buratti E, Vorechovsky I. 2009. Ab initio prediction of mutation-induced cryptic splice-site activation and exon skipping. Eur J Hum Genet 17:759-765.
11. Dominski Z, Kole R. 1991. Selection of splice sites in pre-mRNAs with short internal exons. Mol Cell Biol 11(12):6075-6083.
12. Dominski Z, Kole R. 1992. Cooperation of pre-mRNA sequence elements in splice site selection. Mol Cell Biol 12:2108-2114.
13. Goren A, Kim E, Amit M, Vaknin K, Kfir N, Ram O, Ast G. 2010. Overlapping splicing regulatory motifs-combinatorial effects on splicing. Nucleic Acids Res 38:3318-3327.
14. Graveley BR, Maniatis T. 1998. Arginine/serine-rich domains of SR proteins can function as activators of pre-mRNA splicing. Mol Cell 1:765-771.
15. Hwang DY, Cohen JB. 1997. U1 small nuclear RNA-promoted exon selection requires a minimal distance between the position of U1 binding and the 3′ splice site across the exon. Mol Cell Biol 17:7099-7107.
16. Ibrahim EC, Schaal TD, Hertel KJ, Reed R, Maniatis T. 2005. Serine/arginine-rich protein-dependent suppression of exon skipping by exonic splicing enhancers. Proc Natl Acad Sci USA 102:5002-5007.
17. Jaynes E. 1957. Information theory and statistical mechanics. Phys Rev 106:620-630.
18. Lim KH, Ferraris L, Filloux ME, Raphael BJ, Fairbrother WG. 2011. Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes. Proc Natl Acad Sci USA 108(27):11093-11098.
19. Liu HX, Chew SL, Cartegni L, Zhang MQ, Krainer AR. 2000. Exonic splicing enhancer motif recognized by human SC35 under splicing conditions. Mol Cell Biol 20:1063-1071.
20. Liu HX, Zhang M, Krainer AR. 1998. Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes Dev 12:1998-2012.
21. Macias-Vidal J, Rodes M, Hernandez-Perez JM, Vilaseca MA, Coll MJ. 2009. Analysis of the CTNS gene in 32 cystinosis patients from Spain Clin Genet 76:486-489.
22. Mucaki EJ, Ainsworth P, Rogan PK. 2011. Comprehensive prediction of mRNA splicing effects of BRCA1 and BRCA2 variants. Hum Mutat 32(7):735-742. doi: 10.1002/humu.21513. Epub 2011 May 5.
23. Nalla VK, Rogan PK. 2005. Automated splicing mutation analysis by information theory. Hum Mutat 25:334-342.
24. Robberson BL, Cote GJ, Berget SM. 1990. Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol Cell Biol 10:84-94.
25. Rogan PK, Faux BM, Schneider TD. 1998. Information analysis of human splice site mutations. Hum Mutat 12:153-171.
26. Rogan PK, Svojanovsky SR, Leeder JS. 2003. Information theory-based analysis of CYP219, CYP2D6 and CYP3A5 splicing mutations. Pharmacogenetics 13:207-218.
27. Rogan PK. 2009. Ab initio exon definition using an information theory-based approach. CISS 2009, 43rd Annual Conference on Information Sciences and Systems p. 847-852. doi: 10.1109/CISS.2009.5054835.
28. Rutter JL, Goldstein AM, Davila MR, Tucker MA, Struewing JP. 2003. CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF. Oncogene 22:4444-4448.
29. Sanz DJ, Acedo A, Infante M, Duran M, Perez-Cabornero L, Esteban-Cardenosa E, Lastra E, Pagani F, Miner C, Velasco EA. 2010. A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients. Clin Cancer Res 16:1957-1967.
30. Schneider TD, Stormo GD, Yarus MA, Gold L. 1984. Delila system tools. Nucleic Acids Res 12:129-140.
31. Schneider TD. 1997. Information content of individual genetic sequences. J Theor Biol 189:427-441.
32. Shultzaberger RK, Bucheimer RE, Rudd KE, Schneider TD. 2001. Anatomy of Escherichia coli ribosome binding sites. J Mol Biol 313:215-228.
33. Smith PJ, Zhang C, Wang J, Chew SL, Zhang MQ, Krainer AR. 2006. An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum Mol Genet 15(16):2490-508.
34. Stamm S, Riethoven JJ, Le Texier V, Gopalakrishnan C, Kumanduri V, Tang Y, Barbosa-Morais NL, Thanaraj TA. 2006. ASD: a bioinformatics resource on alternative splicing. Nucl Acids Res 34(suppl 1):D46-D55.
35. Tompson SW, Ruiz-Perez VL, Blair HJ, Barton S, Navarro V, Robson JL, Wright MJ, Goodship JA. 2007. Sequencing EVC and EVC2 identifies mutations in two-thirds of Ellis-van Creveld syndrome patients. Hum Genet 120:663-670.
36. Tribus M. 1961. Thermostatics and thermodynamics: an introduction to energy, information and states of matter, with engineering applications. Princeton, NJ: Van Nostrand, p. 649.